The Bredesen Protocol (ReCODE Diet): Root Causes, Mechanisms & Integrative Protocols

Introduction: Reversing the Irreversible

Alzheimer's disease has long been characterized as an irreversible, progressive neurodegenerative condition with no meaningful disease-modifying treatment. The Bredesen Protocol — formally known as the ReCODE (Reversal of Cognitive Decline) Protocol — challenges this paradigm. Developed by Dr. Dale Bredesen, a neurologist and researcher at the Buck Institute for Research on Aging, the protocol is built on a foundational insight: Alzheimer's disease is not a single-cause condition but a downstream consequence of multiple convergent biological insults that, when addressed systematically, can be reversed or significantly arrested.

Dr. Bredesen's landmark 2014 case series in Aging reported cognitive reversal in 9 of 10 patients with early Alzheimer's or MCI (mild cognitive impairment) using a personalized, multimodal intervention. Subsequent publications and a larger observational study (MPI Cognition, 2022) involving over 25 patients demonstrated sustained cognitive improvement — including on objective neuropsychological testing — in the majority of participants. These results remain unprecedented in the Alzheimer's intervention literature.

The ReCODE Framework: Subtypes of Cognitive Decline

One of the Bredesen Protocol's defining contributions is its recognition that Alzheimer's disease encompasses distinct biological subtypes, each driven by different root causes and requiring different therapeutic emphases:

• Type 1 — Inflammatory ("Hot"): driven by chronic systemic or neuroinflammation; associated with elevated hsCRP, NF-κB activation, infection, gut dysbiosis, and autoimmune activity
• Type 2 — Atrophic ("Cold"): driven by deficiency of neurotrophic and hormonal support; associated with low BDNF, low estrogen/testosterone/progesterone, low vitamin D, low thyroid function, and insulin resistance
• Type 1.5 — Glycotoxic ("Sweet"): a hybrid driven by insulin resistance and glucose dysregulation — the most common subtype in Western populations
• Type 3 — Toxic ("Dementor"): driven by toxic exposures — heavy metals (mercury, lead), mycotoxins (mold), organic toxins, and biotoxins; typically presents earlier (50s–60s) and is frequently misdiagnosed
• Type 4 — Vascular: driven by cerebrovascular compromise, reduced cerebral blood flow, and cardiovascular risk factors
• Type 5 — Traumatic: driven by traumatic brain injury history and associated neuroinflammation

Personalized intervention begins with subtype identification through comprehensive laboratory and clinical assessment, allowing targeted therapeutic prioritization.

Root Causes: What ReCODE Addresses

1. Insulin Resistance and Metabolic Dysfunction

Alzheimer's disease is increasingly referred to as "Type 3 Diabetes" — reflecting the central role of cerebral insulin resistance in amyloid accumulation and synaptic failure. Insulin signaling supports neuronal survival, synaptic plasticity, and glucose metabolism. When insulin resistance develops in the brain, APP (amyloid precursor protein) processing shifts toward amyloidogenic pathways, BDNF declines, and mitochondrial function deteriorates. The ReCODE diet aggressively targets insulin resistance through carbohydrate restriction, intermittent fasting, and metabolic optimization.

2. Neuroinflammation

Amyloid-beta, long characterized as the primary pathological agent in Alzheimer's, is now understood to function as an antimicrobial peptide — produced in response to infection, inflammatory stimulation, or blood-brain barrier breach. Chronic neuroinflammation — driven by gut dysbiosis, systemic infection (HSV-1, Porphyromonas gingivalis, Borrelia, Candida), toxic exposures, and dietary pro-inflammatory patterns — sustains amyloid production and impairs microglial clearance.

3. Trophic and Hormonal Insufficiency

BDNF, NGF (nerve growth factor), estrogen, testosterone, progesterone, thyroid hormones, and vitamin D all support synaptic maintenance and neuronal survival. Their decline — through aging, chronic stress, nutrient depletion, or hormonal dysregulation — shifts the APP processing balance toward synapse elimination. ReCODE addresses trophic insufficiency through dietary, lifestyle, and targeted supplementation interventions.

4. Toxic Burden

Heavy metals (particularly inorganic mercury from dental amalgam and dietary exposure), mycotoxins from water-damaged buildings, and organic toxins (glyphosate, pesticides, air pollutants) are documented neurotoxins that impair mitochondrial function, increase oxidative stress, and trigger neuroinflammatory cascades. Type 3 cognitive decline is defined by this toxic burden and requires specific detoxification support.

5. Vascular and Oxygenation Insufficiency

Reduced cerebral blood flow, sleep apnea (nocturnal hypoxia), and cardiovascular risk factors (hypertension, dyslipidemia, atrial fibrillation) compromise neuronal energy delivery and impair glymphatic clearance — the brain's overnight waste-removal system that clears amyloid and tau during deep sleep.

The ReCODE Diet: Core Nutritional Principles

1. KetoFLEX 12/3: The Foundational Dietary Framework

Dr. Bredesen's dietary approach is formalized as KetoFLEX 12/3 — a flexible, plant-rich, mildly ketogenic diet with structured fasting windows:

• "Keto": mildly ketogenic — targeting mild ketosis (BHB 0.5–4.0 mmol/L) to provide ketone bodies as an alternative fuel for neurons with impaired glucose metabolism. Not strictly ketogenic — moderate carbohydrates from non-starchy vegetables are encouraged.
• "FLEX": flexible — accommodating plant-based, pescatarian, and omnivore approaches. Emphasis on plant diversity; animal products from quality sources.
• "12": minimum 12-hour overnight fast (ideally 14–16 hours) to activate autophagy, glymphatic clearance, and ketogenesis.
• "3": last meal at least 3 hours before sleep to optimize glymphatic function during deep sleep.

2. Macronutrient Framework

• Carbohydrates: primarily from non-starchy vegetables; eliminate refined carbohydrates, sugar, grains (especially gluten), and high-glycemic fruits
• Fats: emphasize MUFA (olive oil, avocado), omega-3s (wild fish, flaxseed), and MCT oil for ketone production
• Protein: moderate; emphasize wild-caught fish, pastured poultry and eggs, legumes; minimize red meat and eliminate processed meat

3. Priority Foods

• Non-starchy vegetables (foundation): leafy greens, cruciferous vegetables, alliums, asparagus, artichokes, zucchini — minimum 6–9 cups/day
• Wild-caught fatty fish: salmon, sardines, mackerel (EPA/DHA for neuronal membrane integrity and anti-inflammatory signaling)
• Avocado and olive oil: MUFA-rich; support lipid metabolism, mitochondrial function, and BBB integrity
• Walnuts and flaxseed: ALA omega-3s, polyphenols, magnesium
• Berries: blueberries and blackberries specifically — anthocyanins cross the BBB and directly reduce neuroinflammation and amyloid burden in preclinical models
• Lion's mane mushroom: contains hericenones and erinacines that stimulate NGF synthesis — the most evidence-supported food source for neurotrophic support
• Eggs (pastured): choline for acetylcholine synthesis and phosphatidylcholine (myelin and neuronal membrane component); lutein for BBB integrity
• Dark chocolate (≥85% cacao): flavonoids, magnesium, BDNF-supportive polyphenols
• MCT oil: rapidly converted to ketone bodies; provides alternative neuronal fuel; supports mild ketosis without strict carbohydrate restriction

4. Foods to Eliminate

• All refined sugar and high-fructose corn syrup
• Gluten-containing grains (wheat, barley, rye) — associated with increased intestinal permeability and neuroinflammation
• Processed and ultra-processed foods
• Industrial seed oils (corn, soybean, canola, sunflower)
• High-mercury fish (tuna, swordfish, king mackerel, tilefish)
• Alcohol (accelerates neurodegeneration and disrupts glymphatic function)
• Dairy — eliminated or minimized; grass-fed ghee and occasionally grass-fed butter may be retained

The Role of Intermittent Fasting

The 12/3 fasting structure in KetoFLEX is not merely metabolic — it is neuroprotective by design. During the fasting window:

• Autophagy is activated — clearing damaged proteins including amyloid oligomers and tau aggregates
• Glymphatic clearance peaks during deep sleep — the brain's drainage system removes metabolic waste including amyloid-beta; this system requires adequate sleep duration and quality, and is disrupted by eating too close to bedtime
• Ketogenesis is initiated — providing BHB as neuronal fuel and as a direct inhibitor of NLRP3 inflammasome activation
• Insulin sensitivity improves — directly addressing the Type 1.5 glycotoxic subtype

Comprehensive Laboratory Assessment

The Bredesen Protocol requires extensive baseline testing to identify individual drivers. Key panels include:

• Metabolic: fasting glucose, insulin, HbA1c, HOMA-IR, lipid particle size (NMR), homocysteine
• Inflammatory: hsCRP, IL-6, TNF-α, ferritin
• Hormonal: free T3/T4/TSH, sex hormones (total and free testosterone, estradiol, progesterone, DHEA-S, pregnenolone), cortisol (4-point salivary)
• Nutritional: vitamin D (25-OH), B12, folate, RBC magnesium, zinc, copper, omega-3 index, CoQ10
• Genetic: ApoE genotype (ApoE4 carriers have 3–15x increased Alzheimer's risk and require stricter dietary and lifestyle adherence)
• Toxin: heavy metals (mercury, lead, arsenic — provoked urine or blood), mycotoxins (urine), C4a, TGF-β1, MMP-9 (biotoxin markers)
• Infectious: HSV-1 IgG/IgM, Lyme panel, dental X-rays (P. gingivalis), gut microbiome analysis
• Cognitive: MoCA, CNS Vital Signs, or BrainHQ baseline; repeat at 3–6 months

ApoE4 Considerations

Approximately 25% of the population carries one ApoE4 allele; 2–3% carry two. ApoE4 carriers have significantly impaired lipid transport in the brain, reduced amyloid clearance, increased neuroinflammatory susceptibility, and altered response to dietary fat. Key ApoE4-specific modifications to KetoFLEX include:

• Emphasize plant-based fats (MUFA from olive oil and avocado) over saturated animal fats
• Prioritize DHA from algae-based sources alongside fish
• More aggressive intermittent fasting and ketosis targets
• Strict elimination of alcohol (ApoE4 carriers have heightened neurotoxic sensitivity)
• Consider phosphatidylserine supplementation to support lipid metabolism in the brain

Targeted Supplementation Framework

• DHA/EPA omega-3: 2–3g/day (emphasize DHA for structural neuronal support)
• Lion's mane mushroom: 500–1,000mg/day (NGF stimulation)
• Bacopa monnieri: 300mg/day (acetylcholinesterase inhibition, antioxidant neuroprotection)
• Ashwagandha: 300–600mg/day (cortisol regulation, BDNF support, amyloid reduction in preclinical models)
• Phosphatidylserine: 100–300mg/day (membrane integrity, cortisol modulation)
• MCT oil / exogenous ketones: for neuronal fuel support
• Magnesium L-threonate: crosses BBB; supports synaptic density and cognitive function
• CoQ10 (ubiquinol): 200–400mg/day (mitochondrial electron transport chain support)
• Vitamin D3/K2: correct to 50–80 ng/mL 25-OH-D
• Methylated B-complex: B6, methylfolate, methylcobalamin — homocysteine reduction (elevated homocysteine is an independent Alzheimer's risk factor)
• Curcumin (liposomal or phytosome): NF-κB inhibition, amyloid disaggregation in preclinical models

Lifestyle Pillars of the Bredesen Protocol

Diet is one component of a multimodal intervention. The full protocol includes:

• Exercise: aerobic exercise 4–5x/week (increases BDNF, improves insulin sensitivity, reduces amyloid burden); strength training 2–3x/week
• Sleep optimization: 7–8 hours nightly; address sleep apnea (CPAP or positional therapy); optimize sleep architecture for deep sleep glymphatic function
• Stress reduction: chronic stress elevates cortisol, reduces BDNF, and accelerates hippocampal atrophy; mindfulness, breathwork, and nature exposure are evidence-supported
• Brain stimulation: BrainHQ or similar adaptive cognitive training; social engagement; learning new skills
• Oral health: aggressive periodontal care — P. gingivalis is documented in Alzheimer's brain tissue and produces gingipain proteases that cleave tau and trigger neuroinflammation
• Toxin avoidance: filter water (reverse osmosis), avoid high-mercury fish, reduce pesticide exposure, assess and remediate mold exposure

Evidence Base and Limitations

The Bredesen Protocol's evidence base is primarily observational and case-series based. Critics appropriately note the absence of large double-blind RCTs — a limitation acknowledged by Dr. Bredesen. However, the mechanistic rationale is extensively grounded in peer-reviewed literature across each individual intervention domain (omega-3s, insulin resistance, sleep, exercise, inflammation), and the clinical outcomes reported in published case series are not achievable through any current pharmaceutical intervention.

A formal RCT (the MPI Cognition trial) is ongoing. In the interim, the protocol's risk-benefit profile is favorable: its interventions — dietary optimization, exercise, sleep, stress reduction, targeted supplementation — carry minimal risk and substantial systemic health benefit independent of cognitive outcomes.

Conclusion: A Precision Approach to an Urgent Problem

The Bredesen Protocol represents the most comprehensive, mechanistically grounded approach to cognitive decline currently available in integrative medicine. By treating Alzheimer's disease as a heterogeneous condition with identifiable, addressable root causes — rather than a singular protein accumulation disorder — it opens a therapeutic window that conventional single-target approaches have consistently failed to exploit.

For individuals with MCI, early Alzheimer's, subjective cognitive impairment, or strong family history and ApoE4 status, early implementation of the ReCODE framework offers the strongest evidence-informed foundation for neuroprotection and cognitive resilience currently available outside of clinical trials.

This article is for educational purposes only and does not constitute medical advice. Individuals with diagnosed cognitive decline or neurological conditions should implement the Bredesen Protocol under the supervision of a qualified healthcare practitioner trained in the ReCODE methodology.